These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11194458)
1. PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer. Levea CM; Mcgary CT; Symons JR; Mooney RA Breast Cancer Res Treat; 2000 Nov; 64(2):221-8. PubMed ID: 11194458 [TBL] [Abstract][Full Text] [Related]
2. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Toh Y; Pencil SD; Nicolson GL Gene; 1995 Jun; 159(1):97-104. PubMed ID: 7607577 [TBL] [Abstract][Full Text] [Related]
4. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue. Yang T; Zhang JS; Massa SM; Han X; Longo FM Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916 [TBL] [Abstract][Full Text] [Related]
5. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Pencil SD; Toth M Clin Exp Metastasis; 1998 Feb; 16(2):113-21. PubMed ID: 9514092 [TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. Newby JC; Johnston SR; Smith IE; Dowsett M Clin Cancer Res; 1997 Sep; 3(9):1643-51. PubMed ID: 9815855 [TBL] [Abstract][Full Text] [Related]
7. Expression of the leucocyte common antigen-related (LAR) tyrosine phosphatase is regulated by cell density through functional E-cadherin complexes. Symons JR; LeVea CM; Mooney RA Biochem J; 2002 Jul; 365(Pt 2):513-9. PubMed ID: 12095414 [TBL] [Abstract][Full Text] [Related]
8. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance]. Yang JQ; Chen L; Xing TY Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828 [TBL] [Abstract][Full Text] [Related]
9. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. Kurbel S Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta production and induction of cellular responses in 13762NF rat mammary adenocarcinoma cell clones. Kaufmann AM; Stoeck M; Schirrmacher V; Lichtner RB Invasion Metastasis; 1993; 13(5):244-52. PubMed ID: 7960577 [TBL] [Abstract][Full Text] [Related]
11. Leukocyte common-antigen-related tyrosine phosphatase receptor: altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma. Yang T; Martignetti JA; Massa SM; Longo FM Carcinogenesis; 2000 Feb; 21(2):125-31. PubMed ID: 10657947 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas. North SM; Steck PA; Nicolson GL Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654 [TBL] [Abstract][Full Text] [Related]
13. EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing. Ruhe JE; Streit S; Hart S; Ullrich A Cell Signal; 2006 Sep; 18(9):1515-27. PubMed ID: 16478662 [TBL] [Abstract][Full Text] [Related]
14. Biomarkers of metastatic potential in cultured adenocarcinoma clones. Dabbous MKh; Jefferson MM; Haney L; Thomas EL Clin Exp Metastasis; 2011 Feb; 28(2):101-11. PubMed ID: 21104427 [TBL] [Abstract][Full Text] [Related]
15. Coexpression of cytokeratins characteristic for myoepithelial and luminal cell lineages in rat 13762NF mammary adenocarcinoma tumors and their spontaneous metastases. Lichtner RB; Julian JA; North SM; Glasser SR; Nicolson GL Cancer Res; 1991 Nov; 51(21):5943-50. PubMed ID: 1718590 [TBL] [Abstract][Full Text] [Related]
16. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast. Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078 [TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors]. Zhang Z; Xu G; Liu S Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761 [TBL] [Abstract][Full Text] [Related]
18. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347 [TBL] [Abstract][Full Text] [Related]
19. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status. Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722 [TBL] [Abstract][Full Text] [Related]
20. LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells. Zhai Y; Wirth J; Kang S; Welsch CW; Esselman WJ Mol Carcinog; 1995 Oct; 14(2):103-10. PubMed ID: 7576097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]